Skip to content

Implementation of and barriers to adherence control for antituberculous therapy in children, adolescents and young adults in Germany

Implementation of and barriers to adherence control for antituberculous therapy in children, adolescents and young adults in Germany

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035238
Enrollment
200
Registered
2024-12-19
Start date
2025-03-24
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis A15-A19

Interventions

Group 1: Physicians in clinics/practices and public health services who are involved in the anti-tuberculosis therapy of children, adolescents and young adults are prospectively surveyed once as part

Sponsors

Universitätsklinikum Freiburg, Klinik für Kinder- und Jugendmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All active physicians in clinics and in private practice who have professional experience in the treatment of children, adolescents and young adults with tuberculosis, as well as social workers in youth facilities who have experience in providing treatment support for unaccompanied minor asylum seekers with tuberculosis, are included in the questionnaire and interviews. Interviews are also conducted with employees in health authorities who are involved in the coordination of tuberculosis therapy for children, adolescents and young adults.

Exclusion criteria

Exclusion criteria: All those who do not meet the inclusion criteria, minors

Design outcomes

Primary

MeasureTime frame
Identification of frequently used practices regarding anti-tuberculous therapy monitoring of children, adolescents and young adults in Germany through physicians and social workers via a prospective data collection by means of a self-administered web survey. The data collection will take place within 6 months, probably starting in January 2025.

Secondary

MeasureTime frame
Identification of barriers and facilitators in the coordination and implementation of therapy monitoring for public health services, physicians and social workers in youth facilities via guided individual interviews in the data collection phase of 6 months from January 2025 onwards via an online conference tool (Webex).

Countries

Germany

Contacts

Public ContactBenedikt Spielberger

Universitätsklinikum Freiburg, Kinder- und Jugendklinik Freiburg, Sektion für pädiatrische Rheumatologie/Infektiologie

benedikt.spielberger@uniklinik-freiburg.de+4976127043000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026